High profile junk reporting is going to sell a lot of this junk vaccine — buyer beware!
June 18, 2013 – High profile junk reporting is going to sell a lot of this junk vaccine. When The New York Times goes weak in the knees for Merck's Gardasil, a lot of crazy claims get tossed around... Read More >


